申请人:Janssen Pharmaceutica NV
公开号:US20200055874A1
公开(公告)日:2020-02-20
Sultam compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with the KEAP1-Nrf2 interaction, such as inflammatory bowel disease, including Crohn's disease and ulcerative colitis.
Sultam化合物,含有它们的药物组合物,制备它们的方法,以及使用它们的方法,包括用于治疗与KEAP1-Nrf2相互作用相关的疾病状态、疾病和病况的方法,如炎症性肠病,包括克罗恩病和溃疡性结肠炎。